NCT06925204

Brief Summary

The goal of this observational study is to establish a prospective cohort of chronic pancreatitis (CP) patients to provide evidence-based guidance for clinical practice and comprehensively optimize diagnostic and treatment strategies. The study aims to collect detailed demographic information, clinical data, medical imaging, biological samples, and follow-up information from CP patients.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
116mo left

Started Apr 2025

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Apr 2025Dec 2035

First Submitted

Initial submission to the registry

March 20, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 13, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

April 13, 2025

Completed
10.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2035

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2035

Last Updated

April 15, 2025

Status Verified

April 1, 2025

Enrollment Period

10.6 years

First QC Date

March 20, 2025

Last Update Submit

April 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of complications

    The incidence of complications after the diagnosis of chronic pancreatitis, including diabetes mellitus, pancreatic exocrine insufficiency, pancreatic pseudocyst, biliary stricture, pancreatic portal hypertension, and pancreatic fistula.

    Annually for 10 years post-enrollment (Year 1 through Year 10)

Secondary Outcomes (6)

  • Incidence of pancreatic cancer

    5 and 10 years after enrollment

  • Efficacy of endoscopic treatment

    1 year after treatment

  • Scores of quality of life

    Annually for 10 years post-enrollment (Year 1 through Year 10)

  • HbA1c level

    Baseline and Year 1 to Year 10 post-enrollment (annually)

  • Blood glucose profile characteristics

    Baseline and Year 1 to Year 10 post-enrollment (annually)

  • +1 more secondary outcomes

Study Arms (1)

chronic pancreatitis

This group included all enrolled patients with CP.

Other: Observation

Interventions

Based on the patient's specific clinical condition, the appropriate examination and treatment in accordance with the conventional diagnosis and treatment standards of CP will be performed, including but not limited to: CT, MRI, endoscopic ultrasound (EUS) with or without biopsy, endocrine hormone testing (such as oral glucose tolerance test or mixed meal tolerance testing), pancreatic exocrine function tests (such as fecal elastase-1 test), extracorporeal shock wave lithotripsy (ESWL), endoscopic retrograde cholangiopancreatography (ERCP), and pancreatic enzyme replacement therapy. Patients were followed up regularly.

chronic pancreatitis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Chronic pancreatitis patients in China.

You may qualify if:

  • Patients diagnosed with chronic pancreatitis.

You may not qualify if:

  • Patients who refuse to sign informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhai Hospital

Shanghai, Shanghai Municipality, China

RECRUITING

Related Publications (4)

  • Kichler A, Jang S. Chronic Pancreatitis: Epidemiology, Diagnosis, and Management Updates. Drugs. 2020 Aug;80(12):1155-1168. doi: 10.1007/s40265-020-01360-6.

  • Oh TK, Song IA. Five-year mortality trends associated with chronic pancreatitis in South Korea: A population based cohort study. Pancreatology. 2020 Jul;20(5):828-833. doi: 10.1016/j.pan.2020.04.024. Epub 2020 Jun 18.

  • Sellers ZM, MacIsaac D, Yu H, Dehghan M, Zhang KY, Bensen R, Wong JJ, Kin C, Park KT. Nationwide Trends in Acute and Chronic Pancreatitis Among Privately Insured Children and Non-Elderly Adults in the United States, 2007-2014. Gastroenterology. 2018 Aug;155(2):469-478.e1. doi: 10.1053/j.gastro.2018.04.013. Epub 2018 Apr 13.

  • Wang LW, Li ZS, Li SD, Jin ZD, Zou DW, Chen F. Prevalence and clinical features of chronic pancreatitis in China: a retrospective multicenter analysis over 10 years. Pancreas. 2009 Apr;38(3):248-54. doi: 10.1097/MPA.0b013e31818f6ac1.

Biospecimen

Retention: SAMPLES WITH DNA

The patient's stool, blood, urine, pancreatic tissue and pancreatic stones generated during the diagnosis and treatment will be retained.

MeSH Terms

Conditions

Pancreatitis, Chronic

Interventions

Observation

Condition Hierarchy (Ancestors)

PancreatitisPancreatic DiseasesDigestive System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Zhaoshen Li, M.D.

    Changhai Hospital

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 20, 2025

First Posted

April 13, 2025

Study Start

April 13, 2025

Primary Completion (Estimated)

December 1, 2035

Study Completion (Estimated)

December 31, 2035

Last Updated

April 15, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations